The Cancer Center Support Grant (CCSG) is administered by the Koch Institute for Integrative Cancer Research at MIT under the direction of Cynthia Quense, the Assistant Director for Administration. The Koch Institute has a centralized administrative system to support the Members within the Koch Institute building. This structure allows for knowledge and specialization within functional areas while providing administrative staff that are very familiar with the individualized needs of Members and their respective laboratories. The central administrative team (known as the Headquarters Office (HQ)) provides full support in the following key areas: CCSG Administration Processes & Administrative Oversight Koch Institute Leadership, Executive Committee and CCSG / Faculty Meetings Scientific Advisory Board support Koch Institute Membership Processes Faculty Recruitment & Retention ? coordinated with Academic Departments Finance: pre and post award and discretionary fund oversight Pilot Project and Fellowship Award Processes Program and Grant Administration Human Resources (HR) Operations & Space Management (Including renovations, facilities & building maintenance) Reception and Office Management Koch Institute Events and Community activities Coordination and oversight of research administration areas including Environment, Health, and Safety (EHS), Core Facilities and faculty Lab Managers and Administrative Assistants Coordination and linking with MIT Administrative Offices and Academic Departments In addition, the HQ team provides CCSG-specific administrative support to Cancer Center Members outside of the building in the areas of: core facilities operations and billing, membership, program support, funding announcements, Pilot Project and other internal funding processes including cancer-related fellowships. Full administrative support is provided to the entire membership for collaborative grants, including the current U54s; PS-OC and CSBC; as well as donor-sponsored centers and initiatives such as the Marble Center for Cancer Nanomedicine, the Center for Precision Cancer Medicine, the Ludwig Center for Molecular Oncology at MIT and the Stem Cell Initiative.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA014051-49
Application #
9937087
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
49
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Type
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Ramadi, Khalil B; Dagdeviren, Canan; Spencer, Kevin C et al. (2018) Focal, remote-controlled, chronic chemical modulation of brain microstructures. Proc Natl Acad Sci U S A 115:7254-7259
Tam, Brooke E; Hao, Yining; Sikes, Hadley D (2018) An examination of critical parameters in hybridization-based epigenotyping using magnetic microparticles. Biotechnol Prog 34:1589-1595
Sabari, Benjamin R; Dall'Agnese, Alessandra; Boija, Ann et al. (2018) Coactivator condensation at super-enhancers links phase separation and gene control. Science 361:
Knouse, Kristin A; Lopez, Kristina E; Bachofner, Marc et al. (2018) Chromosome Segregation Fidelity in Epithelia Requires Tissue Architecture. Cell 175:200-211.e13
Fiedler, Eleanor R C; Bhutkar, Arjun; Lawler, Emily et al. (2018) In vivo RNAi screening identifies Pafah1b3 as a target for combination therapy with TKIs in BCR-ABL1 + BCP-ALL. Blood Adv 2:1229-1242
Clancy-Thompson, Eleanor; Devlin, Christine A; Tyler, Paul M et al. (2018) Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8+ T Cell-Effector Responses. Cancer Immunol Res 6:1524-1536
Miller, Eric A; Baniya, Subha; Osorio, Daniel et al. (2018) Paper-based diagnostics in the antigen-depletion regime: High-density immobilization of rcSso7d-cellulose-binding domain fusion proteins for efficient target capture. Biosens Bioelectron 102:456-463
Sullivan, Lucas B; Luengo, Alba; Danai, Laura V et al. (2018) Aspartate is an endogenous metabolic limitation for tumour growth. Nat Cell Biol 20:782-788
Filbin, Mariella G; Tirosh, Itay; Hovestadt, Volker et al. (2018) Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq. Science 360:331-335
Lannagan, Tamsin R M; Lee, Young K; Wang, Tongtong et al. (2018) Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis. Gut :

Showing the most recent 10 out of 904 publications